Supernus Pharmaceuticals (SUPN) Goodwill & Intangibles (2011 - 2026)

Supernus Pharmaceuticals (SUPN) has 16 years of Goodwill & Intangibles data on file, last reported at $670.4 million in Q1 2026.

• On a quarterly basis, Goodwill & Intangibles rose 8.28% year-over-year to $670.4 million in Q1 2026; TTM through Mar 2026 was $670.4 million, a 8.28% increase from a year earlier, with the FY2025 full-year figure at $694.3 million, up 8.67% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $670.4 million, down from $694.3 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for SUPN reached as high as $879.5 million in Q1 2022 and fell as low as $598.3 million in Q2 2025.
• Historically, Goodwill & Intangibles has averaged $732.1 million across 5 years, with a median of $716.9 million in 2023.
• Across the five-year window, Goodwill & Intangibles surged 101.41% in 2022 and fell 13.32% in 2024, its largest moves.
• Year by year, Goodwill & Intangibles stood at $819.5 million in 2022, then slipped by 12.52% to $716.9 million in 2023, then decreased by 10.88% to $638.9 million in 2024, then grew by 8.67% to $694.3 million in 2025, then slipped by 3.45% to $670.4 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $670.4 million in Q1 2026, $694.3 million in Q4 2025, and $742.6 million in Q3 2025.